Wall Street analysts forecast that DexCom (DXCM) will report quarterly earnings of $0.65 per share in its upcoming release, pointing to a year-over-year increase of 44.4%. It is anticipated that ...
Q4 2025 Earnings Call February 12, 2026 4:30 PM ESTCompany ParticipantsSean Christensen - Vice President of Finance and ...
New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.
Dexcom announced a new wave of AI-powered features designed to help users understand how food and daily habits affect their metabolic health.
DexCom DXCM received a warning letter from the FDA on March 4, 2025, following inspections of its San Diego and Mesa facilities in 2024. The FDA cited deficiencies in the company’s manufacturing ...
Abbott Diabetes Care has recalled some of its FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitor sensors for people ...
The FDA has escalated the recall of specific Abbott FreeStyle Libre 3 and 3 Plus CGMs to Class I, the highest level of ...
In his first solo album in almost five years, Nick Jonas referenced his health struggle in the song 'Sweet to Me' from the ...
ON Semiconductor Corporation (NASDAQ:ON) Q4 2025 Earnings Call Transcript February 9, 2026 ON Semiconductor Corporation ...
Detailed price information for Senseonics Holdings Inc (SENS-Q) from The Globe and Mail including charting and trades.
This guide will walk you through the Scientist quest in Abyss, giving you locations for all the items need to fix the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results